Inventor
WELLER DWIGHT D
US62 patents
⚠️ This page may combine multiple inventors who share the name “WELLER DWIGHT D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVI BIOPHARMA INC
11 patentsUS6030941AFeb 29, 2000
Polymer composition for delivering substances in living organisms
AVI BIOPHARMA INC160 citations99
US7943762B2May 17, 2011
Oligonucleotide analogs having cationic intersubunit linkages
AVI BIOPHARMA INC153 citations98
US7507196B2Mar 24, 2009
Antisense antiviral compounds and methods for treating a filovirus infection
AVI BIOPHARMA INC60 citations98
US7094765B1Aug 22, 2006
Antisense restenosis composition and method
AVI BIOPHARMA INC129 citations98
US7888012B2Feb 15, 2011
Antisense composition and method for treating muscle atrophy
AVI BIOPHARMA INC56 citations97
US6060246AMay 9, 2000
Reagent and method for isolation and detection of selected nucleic acid sequences
AVI BIOPHARMA INC183 citations97
US8030291B2Oct 4, 2011
Antisense antiviral compounds and methods for treating a filovirus infection
AVI BIOPHARMA INC31 citations96
US8030292B2Oct 4, 2011
Antisense antiviral compounds and methods for treating a filovirus infection
AVI BIOPHARMA INC31 citations96
US8053420B2Nov 8, 2011
Peptide conjugated, inosine-substituted antisense oligomer compound and method
AVI BIOPHARMA INC15 citations92
US7625873B2Dec 1, 2009
Antisense antibacterial method and compound
AVI BIOPHARMA INC34 citations91
US6124271ASep 26, 2000
Method and conjugate for treating H. pylori infection
AVI BIOPHARMA INC21 citations91
SAREPTA THERAPEUTICS INC
11 patentsUS9249243B2Feb 2, 2016
Antibacterial antisense oligonucleotide and method
SAREPTA THERAPEUTICS INC13 citations92
US10479996B2Nov 19, 2019
Antisense antiviral compound and method for treating ss/RNA viral infection
SAREPTA THERAPEUTICS INC4 citations84
US9278987B2Mar 8, 2016
Functionally-modified oligonucleotides and subunits thereof
SAREPTA THERAPEUTICS INC12 citations84
US10006031B2Jun 26, 2018
Antisense composition and method for treating muscle atrophy
SAREPTA THERAPEUTICS INC7 citations83
US9499583B2Nov 22, 2016
Antibacterial antisense oligonucleotide and method
SAREPTA THERAPEUTICS INC3 citations83
US9469664B2Oct 18, 2016
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
SAREPTA THERAPEUTICS INC6 citations82
US11208655B2Dec 28, 2021
Functionally-modified oligonucleotides and subunits thereof
SAREPTA THERAPEUTICS INC1 citations73
US10344281B2Jul 9, 2019
Functionally-modified oligonucleotides and subunits thereof
SAREPTA THERAPEUTICS INC1 citations73
US9790499B2Oct 17, 2017
Functionally-modified oligonucleotides and subunits thereof
SAREPTA THERAPEUTICS INC3 citations73
US10626396B2Apr 21, 2020
Antisense composition and method for treating muscle atrophy
SAREPTA THERAPEUTICS INC2 citations72
US10144762B2Dec 4, 2018
Antibacterial antisense oligonucleotide and method
SAREPTA THERAPEUTICS INC2 citations72
IVERSEN PATRICK L
6 patentsUS8906872B2Dec 9, 2014
Antisense antiviral compound and method for treating ssRNA viral infection
IVERSEN PATRICK L36 citations98
US8877725B2Nov 4, 2014
Peptide conjugated, inosine-substituted antisense oligomer compound and method
IVERSEN PATRICK L49 citations97
US8067569B2Nov 29, 2011
Splice-region antisense composition and method
IVERSEN PATRICK L52 citations97
US8785410B2Jul 22, 2014
Antisense composition and method for treating muscle atrophy
IVERSEN PATRICK L46 citations96
US8084433B2Dec 27, 2011
Antisense antiviral compound and method for treating ssRNA viral infection
IVERSEN PATRICK L34 citations96
US8198429B2Jun 12, 2012
Antisense antiviral compounds and methods for treating a filovirus infection
IVERSEN PATRICK L17 citations93
ANTI GENE DEV GROUP
5 patentsUS5405938AApr 11, 1995
Sequence-specific binding polymers for duplex nucleic acids
ANTI GENE DEV GROUP1,281 citations99
US5185444AFeb 9, 1993
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
ANTI GENE DEV GROUP2,014 citations99
US5166315ANov 24, 1992
Sequence-specific binding polymers for duplex nucleic acids
ANTI GENE DEV GROUP1,783 citations99
US5034506AJul 23, 1991
Uncharged morpholino-based polymers having achiral intersubunit linkages
ANTI GENE DEV GROUP3,553 citations99
US5235033AAug 10, 1993
Alpha-morpholino ribonucleoside derivatives and polymers thereof
ANTI GENE DEV GROUP2,054 citations97
STEIN DAVID A
5 patentsUS8524676B2Sep 3, 2013
Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds
STEIN DAVID A39 citations94
US8785407B2Jul 22, 2014
Antisense antiviral agent and method for treating ssRNA viral infection
STEIN DAVID A38 citations92
US8759307B2Jun 24, 2014
Oligonucleotide compound and method for treating nidovirus infections
STEIN DAVID A35 citations92
US8168604B2May 1, 2012
Antisense antiviral compounds and methods for treating a filovirus infection
STEIN DAVID A29 citations92
US8329668B2Dec 11, 2012
Antisense antiviral compound and method for treating picornavirus infection
STEIN DAVID A20 citations89
ANTIVIRALS INC
4 patentsUS5698685ADec 16, 1997
Morpholino-subunit combinatorial library and method
ANTIVIRALS INC756 citations98
US5521063AMay 28, 1996
Polynucleotide reagent containing chiral subunits and methods of use
ANTIVIRALS INC388 citations98
US5506337AApr 9, 1996
Morpholino-subunit combinatorial library and method
ANTIVIRALS INC854 citations98
US5378841AJan 3, 1995
Alpha-morpholino ribonucleoside derivatives and polymers thereof
ANTIVIRALS INC47 citations91
WELLER DWIGHT D
2 patentsMOURICH DAN V
2 patentsHANSON GUNNAR J
1 patentREEVES MATTHEW DALE
1 patentFOX CHRISTINA MARY JOSEPHINE
1 patentUS DEPARTMENT OF HEALTH & HUMA
1 patentShowing the top 50 of 62 patents by PatentIndex Score.